Skip to Main Content

INFORMATION FOR

Headaches, Phase I

Repeat Dosing of Psilocybin in Migraine Headache

What is the purpose of this trial?

In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.

Contact Information

For more information about this study, including how to volunteer, contact Mackenzie Creighton

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    12/22/2022
  • Study HIC
    #2000026974